Viatris (VTRS) stock and Opus Genetics (IRD) stock gain as the FDA reviews a label expansion for their jointly developed eyecare therapy, Ryzumvi. Read more here.

Venice’s ancient walls are unaccustomed to the scent of fresh paint, let alone street art. Taron Manukyan stood before that historical silence, a spray can in hand. In a city where every stone is a ...

Min Read In late February, people in the Northern Hemisphere can look up for a special sight : Six planets will all be ...